BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38026942)

  • 1. Antihypertensive medications and risk of colorectal cancer in British Columbia.
    Qi J; Bhatti P; Spinelli JJ; Murphy RA
    Front Pharmacol; 2023; 14():1301423. PubMed ID: 38026942
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hypertensive medications and risk of colorectal cancer: a systematic review and meta-analysis.
    Qi J; An R; Bhatti P; Spinelli JJ; Murphy RA
    Cancer Causes Control; 2022 Jun; 33(6):801-812. PubMed ID: 35314908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study.
    Cho IJ; Shin JH; Jung MH; Kang CY; Hwang J; Kwon CH; Kim W; Kim DH; Lee CJ; Kang SH; Lee JH; Kim HL; Kim HM; Cho I; Lee HY; Chung WJ; Ihm SH; Kim KI; Cho EJ; Sohn IS; Park S; Shin J; Ryu SK; Kim JY; Kang SM; Cho MC; Pyun WB; Sung KC
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
    Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
    Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
    Reding KW; Aragaki AK; Cheng RK; Barac A; Wassertheil-Smoller S; Chubak J; Limacher MC; Hundley WG; D'Agostino R; Vitolins MZ; Brasky TM; Habel LA; Chow EJ; Jackson RD; Chen C; Morgenroth A; Barrington WE; Banegas M; Barnhart M; Chlebowski RT
    Oncologist; 2020 Aug; 25(8):712-721. PubMed ID: 32250503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
    Holmes S; Griffith EJ; Musto G; Minuk GY
    Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
    Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
    CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands.
    Schroevers JL; Hoevenaar-Blom MP; Busschers WB; Hollander M; Van Gool WA; Richard E; Van Dalen JW; Moll van Charante EP
    Lancet Reg Health Eur; 2024 Jul; 42():100927. PubMed ID: 38800111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population-Based Case-Control Study.
    Falhammar H; Skov J; Calissendorff J; Nathanson D; Lindh JD; Mannheimer B
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3696-705. PubMed ID: 32285124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive medications and the risk of kidney stones in older adults: a retrospective cohort study.
    Alexander RT; McArthur E; Jandoc R; Welk B; Hayward JS; Jain AK; Braam B; Flockerzi V; Garg AX; Quinn RR
    Hypertens Res; 2017 Sep; 40(9):837-842. PubMed ID: 28331214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
    Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
    Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
    Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
    Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uses and expenses of antihypertensive medications among hypertensive adults.
    Park C; Wang G; Ng BP; Fang J; Durthaler JM; Ayala C
    Res Social Adm Pharm; 2020 Feb; 16(2):183-189. PubMed ID: 31085142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis.
    Jiang W; He R; Lu Y; Zhou W
    Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):547-553. PubMed ID: 35686669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive medication use and ovarian cancer survival.
    Huang T; Townsend MK; Dood RL; Sood AK; Tworoger SS
    Gynecol Oncol; 2021 Nov; 163(2):342-347. PubMed ID: 34556331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
    Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of angiotensin receptor blockers and the risk of cancer.
    Azoulay L; Assimes TL; Yin H; Bartels DB; Schiffrin EL; Suissa S
    PLoS One; 2012; 7(12):e50893. PubMed ID: 23251399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.
    Kim HL; Hwang D; Lee JH; Lee HY; Ihm SH; Kim KI; Shin J; Park S; Kim DH; Sung KC
    Hypertens Res; 2022 May; 45(5):758-768. PubMed ID: 35338336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
    Lee YC; Lin CH; Wu RM; Lin JW; Chang CH; Lai MS
    PLoS One; 2014; 9(6):e98961. PubMed ID: 24910980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.